Credits Available: 3.50 AMA PRA Category 1 Credits™ and ANCC contact hours

Acute myeloid leukemia (AML) continues to be the most common acute leukemia in adults, with an incidence of 5.5 cases per 100,000 persons annually. As such, more education is needed on key topics including use of induction therapy in the non-elderly population, treating suboptimal response to induction therapy, best practices for measurable (or minimal) residual disease assessment, and proper use of maintenance therapy..The goal of this educational curriculum, Turning Complexity into Clarity in AML, is to establish impactful small group interactions between members of the AML care team that will, through a variety of collaborative educational experiences, help them in learning and sharing best practices that will improve outcomes for patients with AML.


CME/CE Accreditation Information

Itinerary

Part 1

Turning Complexity into Clarity in AML - Baseline Assessment

The following questions are intended to assess your knowledge and practice of key aspects in the management of patients with AML. 

Self Study Module 1: Background and Use of Hypomethylating Agents in AML

This module will provide an overview of the background and use of hypomethylating agents in AML.

Self Study Module 2: Options After Suboptimal Response to Chemotherapy: Case-Based Scenarios

This module will discuss options after suboptimal response chemotherapy in the format of case-based scenarios.

Self Study Module 3: Measurable/Minimal Residual Disease (MRD) in AML Clinical Practice

This module will discuss measurable/minimal residual disease in AML clinical practice.

Self Study Module 4: Maintenance Therapy in AML

This module will discuss maintenance therapy in AML.

Turning Complexity into Clarity in AML - Final Assessment

The following questions will assess changes in your knowledge and practice of key aspects in the management of patients with AML based off of your participation in this educational initiative.

Part 2

AML Group Task: Jane's Case

This group task activity has been designed for the learner to explore a patient case study and to apply the knowledge they have learned throughout the activity to determine the most appropriate way to treat the patient.

Live Group Discussion #1: Key Insights on AML

This virtual live discussion provides an opportunity for the group to convene with their group leader to discuss aspects of the self-study learning modules.

AML Group Task: Roger's Case

This group task activity has been designed for the learner to explore a patient case study and to apply the knowledge they have learned throughout the activity to determine the most appropriate way to treat the patient.

Meet & Greet

Please join me for a brief kick off where you'll have a chance to greet other group members and discuss our collective goals and priorities for the next few weeks. I’m really looking forward to seeing you.

Live Group Discussion #2: AML Take-Home Messages: Putting the Evidence to Practice

This virtual live discussion provides an opportunity for the group to convene with their group leader to discuss aspects of the case-based group tasks.

Curriculum is Currently Closed

Thank you for your interest. Currently, the curriculum is closed for enrollment but we encourage you to keep an eye out for future opportunities or alternative programs that might align with your educational goals.

View Other Offerings

Completed Groups

Harry Erba, MD, PhD
Professor of Medicine, Director of the Leukemia Program
Completed
David Sallman, MD
MD
Completed
Catherine Lai, MD, MPH
Associate Professor/Physician Leader, Leukemia Clinical Research Unit
Completed
Douglas Tremblay, MD
Assistant Professor
Completed
Richard Stone, MD
Chief of Staff
Completed
Joshua Zeidner, MD
Associate Professor of Medicine
Completed
Amandeep Salhotra, md
Associate Professor
Completed
David Sallman, MD
MD
Completed
Eric Winer, MD
Assistant Professor, Clinical Director
Completed
Nicholas Short, MD
Assistant Professor
Completed